静岡済生会総合病院は、静岡県静岡市駿河区小鹿一丁目に存在し、社会福祉法人恩賜財団済生会が運営する医療機関。

During the past decade, Shizuoka Saiseikai General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shizuoka Saiseikai General Hospital" are "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Leiomyoma" (1 trials) and "Uterine Fibroids and Heavy Menstrual Bleeding" (1 trials). Many other conditions were trialed in "Shizuoka Saiseikai General Hospital" in a lesser frequency.

Most popular intervention types in "Shizuoka Saiseikai General Hospital" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "Vilaprisan (BAY1002670)" (2 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shizuoka Saiseikai General Hospital" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Shizuoka Saiseikai General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Shizuoka Saiseikai General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shizuoka Saiseikai General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".